Tag

Acromegaly

All articles tagged with #acromegaly

"Uncovering a Hidden Tumor Through Old Photos: A Woman's Startling Discovery"

Originally Published 2 years ago — by New York Post

Featured image for "Uncovering a Hidden Tumor Through Old Photos: A Woman's Startling Discovery"
Source: New York Post

Shari Dawson discovered she had a hidden tumor after noticing changes in her jaw and experiencing various health issues. It took almost a decade for her to be diagnosed with acromegaly, a rare condition caused by a pituitary tumor. Despite undergoing surgery and medication, she still faces challenges, including fertility issues. Now the general manager of the Australian Pituitary Foundation, she aims to raise awareness about the condition to help others receive earlier diagnoses and treatment.

"The Remarkable Growth Journey of the World's Sole Dwarf-Giant"

Originally Published 2 years ago — by Boing Boing

Adam Rainer, born in 1899, is the only person in recorded history to have been classified both as a dwarf and a giant. Standing at 4'10" in early adulthood, he began to grow rapidly at age 21 due to acromegaly caused by a pituitary tumor, eventually reaching 7'8". Despite surgery to remove the tumor, his growth continued, leading to severe health issues. Rainer passed away in 1950 at the age of 51, his life marked by his unique medical condition.

Crinetics' Acromegaly Drug Shows Promise in Phase 3 Trial, Faces Tough Competition

Originally Published 2 years ago — by STAT

Featured image for Crinetics' Acromegaly Drug Shows Promise in Phase 3 Trial, Faces Tough Competition
Source: STAT

Crinetics Pharmaceuticals' experimental drug for acromegaly, a rare hormonal disorder, has shown success in a late-stage trial, with 25 out of 30 patients given the drug achieving normal growth-factor levels compared to just 1 out of 28 participants who took the placebo. The company plans to file for FDA approval pending positive results from a second Phase 3 trial. However, if approved, Crinetics would face tough competition from existing blockbuster therapies sold by pharmaceutical giants in the crowded market.